Coronary angioplasty in diabetic patients: The National Heart, Lung, and Blood Institute percutaneous transluminal coronary angioplasty registry

Circulation

Volumn 94, Issue 8, 1996, Pages 1818-1825

  Kip, Kevin E ^a   Faxon, David P ^b   Detre, Katherine M ^a   Yeh, Wanlin ^a   Kelsey, Sheryl F ^a   Currier, Jesse W ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

angioplasty; cardiovascular diseases; diabetes mellitus; follow up studies; myocardial infarction

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0029972376     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.8.1818     Document Type: Article

References (35)

1. Fein FS, Scheuer J. Heart disease in diabetes. In: Rifkin H, Porte D Jr, eds. Ellenberg and Rifkin's Diabetes Mellitus Theory and Practice. 4th ed. New York, NY: Elsevier Science Publishing Corp; 1990: 812-823.
2. Hambly RI, Sherman L, Mehta J, Aintablian A. Reappraisal of the role of the diabetic state in coronary artery disease. Chest. 1976;70: 251-257.
3. Robertson WB, Strong JP. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:538-551.
4. Waller BF, Palumbo PJ, Lie JT, Roberts WC Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med. 1980;69:498-506.
5. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
6. Waller BF, Palumbo PJ, Lie JT, Roberts WC. The heart in diabetes mellitus as viewed from a morphologic perspective. In: Scott RC, ed. Clinical Cardiology and Diabetes. Mount Kisco, NY: Futura Publishing Co; 1981:84-94.
7. Barrett-Connor E, Orchard TJ. Diabetes in America: Diabetes Data Compiled 1984. Bethesda, Md: US Dept of Health and Human Services; 1985:XVI1-XVI41. NIH publication 85-1468.
8. Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetic patients: fact or fiction? Circulation. 1978;57:133-136.
9. Alderman EL, Corley SD, Fisher LD, Chairman BR, Faxon DP, Foster ED, Killip T, Sosa JA, Bourassa MG, and the CASS Participating Investigators and Staff. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1993; 22:1141-1154.
10. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, Reves JG, Rankin JS. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991;84 (suppl III):III-275-III-284.
11. Vandormael M, Deligonul U, Taussig S, Kern MJ. Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1991;67:1-6.
12. Mick MJ, Piedmonte MR, Arnold AM, Simpfendorfer C. Risk stratification for long-term outcome after elective coronary angioplasty: a multivariate analysis of 5,000 patients. J Am Coll Cardiol. 1994; 24:74-80.
13. Stein B, Weintraub WS, Gebhart SSP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB III. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91: 979-989.
14. Deligonul U, Vandormael M, Kern MJ, Galan K. Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events. Am Heart J. 1989;117:997-1002.
15. Myler RK, Topol EJ, Shaw RE, Stertzer SH, Clark DA, Fishman J, Murphy MC. Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn. 1987;13:1-15.
16. Weintraub WS, Kosinski AS, Brown CL III, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 1993;21:6-14.
17. Bourassa MG, Lespérance J, Eastwood C, Schwartz L, Côté G, Kazim F, Hudon G. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1991;18:368-376.
18. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, Faxon DP, Gruentzig AR, Kelsey SF, Detre KM, Van Raden MJ, Mock MB. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984; 53:77C-81C.
19. Le Feuvre C, Bonan R, Lespérance J, Gosselin G, Joyal M, Crépeau J. Predictive factors of restenosis after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol. 1994;73:840-844.
20. Macdonald RG, Henderson MA, Hirshfeld JW Jr, Goldberg SH, Bass T, Vetrovec G, Cowley M, Taussig A, Whitworth H, Margolis JR, Hill JA, Jugo R, Pepine CJ, for the M-HEART Group. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty: a report from the M-HEART Group. Am J Cardiol 1990; 66:926-931.
21. Holmes DR Jr, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, Williams DO, Cowley MJ, Faxon DP, Kent KM, Bentivoglio LG, Detre KM, and the Co-Investigators of the NHLBI Registry. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1988;12: 1149-1155.
22. Detre KM, Holubkov R, Kelsey SF, Cowley MJ, Kent KM, Williams DO, Myler RK, Faxon DP, Holmes DR Jr, Bourassa MG, Block P, Gosselin AJ, Bentivoglio LG, Leatherman L, Dorros GR, King SB III, Galichia JP, Al-Bassam M, Leon M, Robertson T, Passamani E, and the Co-Investigators of the NHLBIPTCA Registry. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981: the National Heart, Lung, and Blood Institute Registry. N Engl J Med. 1988;318:265-270.
23. Detre KM, Holubkov R, Kelsey SF, Bourassa MG, Williams DO, Holmes DR Jr, Dorros GR, Faxon DP, Myler RK, Kent KM, Cowley MJ, Cannon R, Robertson T, and Coinvestigators of the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. One-year follow-up results of the 19851986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1989;80: 421-428.
24. Detre KM, Yeh W, Kelsey SF, Williams DO, Desvigne-Nickens P, Holmes DR Jr, Bourassa MG, King SB III, Faxon DP, Kent KM, for the Investigators of the NHLBI Percutaneous Transluminal Coronary Angioplasty Registry. Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA Registry experience. Circulation. 1995;91:2868-2875.
25. Kronmal RA, Davis K, Fisher LD, Jones RA, Gillespie MJ. Data management for a large collaborative clinical trial (CASS: Coronary Artery Surgery Study). Comput Biomed Res. 1978;11:553-566.
26. Bourassa MG, Alderman EL, Bertrand M, de la Fuente L, Gratsianski A, Kaltenback M, King SB III, Nobuyoshi M, Romaniuk P, Ryan TJ, Serruys PW, Smith HC, Sousa JE, Bothig S, Rapaport E. Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty: the International Society and Federation of Cardiology and the World Health Organization. Circulation. 1988;78:780-789.
27. Blackburn H. Classification of the electrocardiogram for population studies: Minnesota Code. 3 Electrocardiol. 1969;2:305-310.
28. Cox DR. Regression models and life tables. J R Statist Soc B. 1972; 74:187-220; with discussion.
29. Hartz AJ, Kuhn EM, Pryor DB, Krakauer H, Young M, Heudebert G, Rimm AA. Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience). Am J Cardiol. 1992;70:179-185.
30. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosenblum J, Cumberland DC, Murphy MC, Hansell HN, Hidalgo B. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol 1992;19:1641-1652.
31. Cowley MJ, Dorros GR, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;53:12C-16C.
32. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1994;330:981-993.
33. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-744.
34. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335: 217-225.
35. Benchimol D, Bonnet J, Benchimol H, Drouillet F, Duplaa C, Couffinhal T, Desgranges C, Bricaud H. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Int J Cardiol. 1993;38:7-18.